1. Medicaid Preferred Drug Lists: Cost Containment and Side Effects

   • Alvin E. Headen Jr

   Introduction 07 February 2013 Pages: 1 - 3

2. The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003

   • Frank R. Lichtenberg

   Original Research 07 February 2013 Pages: 5 - 25

3. Which Physicians are Affected Most by Medicaid Preferred Drug Lists for Statins and Antihypertensives?

   • Jonathan D. Ketcham
   • Andrew J. Epstein

   Original Research 07 February 2013 Pages: 27 - 40

4. Effects of Medicaid Access Restrictions on Statin Utilisation for Patients Treated by Physicians Practising in Poor and Minority Neighbourhoods

   • Alvin E. Headen Jr
   • Neal A. Masia
   • Kirsten J. Axelsen

   Original Research 07 February 2013 Pages: 41 - 53

5. Preferred Drug Lists and Medicaid Prescriptions

   • Tamer Abdelgawad
   • Lisa Egbuonu-Davis

   Original Research 07 February 2013 Pages: 55 - 63

6. Impact of Medicaid Preferred Drug Lists on Therapeutic Adherence

   • David B. Ridley
   • Kirsten J. Axelsen

   Original Research 07 February 2013 Pages: 65 - 78

7. Per-patient-per-month Drug Costs in Medicare Part D Protected Classes

   • Lisa Mucha
   • Neal A. Masia
   • Kirsten J. Axelsen

   Original Research 07 February 2013 Pages: 79 - 84